Epithelial‐to‐mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy
Adjuvant chemotherapy has long been indicated to extend survival in completely resected stage IB to IIIA non-small cell lung cancer (NSCLC). However, there is accumulating evidence that chemotherapy or chemoradiotherapy can induce epithelial-to-mesenchymal transition (EMT) in disseminated or circula...
Main Authors: | Poh, Mau Ern, Liam, Chong Kin, Mun, Kein Seong, Chai, Chee Shee, Wong, Chee Kuan, Tan, Jiunn Liang, Loh, Thian Chee, Chin, Ka Kiat |
---|---|
Format: | Article |
Published: |
Wiley Open Access
2019
|
Subjects: |
Similar Items
-
Epithelial-to-mesenchymal transition (EMT) causing acquired resistance to afatinib in a patient with epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma
by: Poh, Mau Ern, et al.
Published: (2018) -
Regulome of cancer epithelial-mesenchymal transition (EMT)
by: See, Benedict
Published: (2020) -
Hypoxia activated EGFR signaling induces epithelial to mesenchymal transition (EMT)
by: Misra, Ashish, et al.
Published: (2013) -
The role of angiopoietin-like 4 (ANGPTL4) in chemoresistance and autophangy during epithelial-mesenchymal transition (EMT)
by: Lim, Maegan Miang Kee
Published: (2019) -
Multidrug resistance protein 2 genetic polymorphism and colorectal cancer recurrence in patients receiving adjuvant FOLFOX-4 chemotherapy
by: Mirakhorli, Mojgan, et al.
Published: (2013)